Autopsy report · NCT03026231

Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients

“study will be started under a new modified protocol”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

The University of Texas Health Science Center, Houston

Sponsor type

University, hospital or other

Conditions

Parkinson's Disease

Interventions

PRIM-DJ2727; Placebo (for PRIM-DJ2727)

Participants

0

Trials that died the same way

• Study of Stored Tumor Samples in Young Patients With Brain Tumors
  “New Protocol that replaces the current study” (87% match in meaning)
• Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.
  “Study was redeveloped into a new protocol” (87% match in meaning)
• Treatment of Balance Disorders in Parkinson's Patients Using SpotOn Balance Glasses
  “The study protocol needed to be modified” (80% match in meaning)
• OsseoFit™ Prospective Data Collection
  “Planning new study protocol” (76% match in meaning)
• Estimate Serum Oxytocin PD Range in the Periphery
  “Study will be replaced by a revised study protocol” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.